A. Kaltenböck - Concepedia

Author

A. Kaltenböck

Also Known As

A. Kaltenböck, Astrid Kaltenböck

Publications

351

Citations

H-Index

Concepts

All Affiliations

A. Kaltenböck is an author at Intercell (Austria) specializing in medicine, vaccination, and immunology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	253
2	Immunology	3	3	198
3	Allergy	1	1	63
4	Epidemiology	1	1	55
5	Autoimmune Disease	1	1	63

A. Kaltenböck

Publications

347

Citations

H-Index

Page 1

	Year	Citations
Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Trial of the Safety and Tolerability of IC51, an Inactivated Japanese Encephalitis Vaccine Erich Tauber, Herwig Kollaritsch, Frank von Sonnenburg, The Journal of Infectious Diseases	2008	94
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Elisabeth Schuller, Bernd Jilma, V. Voicu, Vaccine VaccinationVaccine DevelopmentVaccine ResearchImmunologyTherapeutic Vaccine	2008	78
Immunogenicity and safety of IXIARO® (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age A. Kaltenböck, Katrin Dubischar-Kastner, Elisabeth Schuller, Vaccine Primary ImmunodeficiencyAllergyAutoimmune DiseaseImmunodeficienciesImmunology	2009	63
Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study A. Kaltenböck, Katrin Dubischar-Kastner, Gerald Eder, Vaccine VaccinologyVaccine SafetyVaccinationInfectious Disease PreventionVaccine Development	2009	57
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study Elisabeth Schuller, Christoph Klade, Gabriele Wölfl, Vaccine VaccinationStandard RegimenMedicineVaccine TrialHigh-dose Vaccination Regimen	2009	55

Page 1